InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,836.40
(
0.99%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.66
(
-0.77%
)
Bitcoin
56,407.01
(
-1.01%
)
Post# of 2342594
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dirkv

Send PM Follow Ignore
Followers 39
Posts 7322
Boards Moderated 0
Alias Born 10/17/2013

dirkv

Re: None

Thursday, 05/01/2014 10:59:02 AM

Thursday, May 01, 2014 10:59:02 AM

Post# of 2342594
ONVO 11:04am EST 6.09 +0.25 +4.25%

Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company?s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up